ES2167563T3 - Derivados de (2-morfolinilmetil)benzamida. - Google Patents

Derivados de (2-morfolinilmetil)benzamida.

Info

Publication number
ES2167563T3
ES2167563T3 ES96916121T ES96916121T ES2167563T3 ES 2167563 T3 ES2167563 T3 ES 2167563T3 ES 96916121 T ES96916121 T ES 96916121T ES 96916121 T ES96916121 T ES 96916121T ES 2167563 T3 ES2167563 T3 ES 2167563T3
Authority
ES
Spain
Prior art keywords
sub
rent
sup
hydrogen
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96916121T
Other languages
English (en)
Inventor
Daele Georges Henri Paul Van
Den Keybus Frans Maria Alf Van
Marc Gustaaf Celine Verdonck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of ES2167563T3 publication Critical patent/ES2167563T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION TRATA DE NUEVOS DERIVADOS DE (2 MORFOLINILMETIL)BENZAMIDA QUE POSEEN LA FORMULA (I), LAS FORMAS DE N Y LAS FORMAS ESTEREOQUIMICAMENTE ISOMERAS DE LOS MISMOS, EN LA CUAL R SUP,1} ES ALQUILO C SUB,1-6}, ALQUENILO C SUB,2-6} O ALQUINILO C SUB,2-6}; R SUP,2} ES HIDROGENO, HALO O ALQUILSULFONILAMINO C SUB,1-6}; R SUP,3} ES HIDROGENO O ALQUILO C SUB,1-6}; L ES UN RADICAL DE FORMULA R SUP,4} 5} LQ IILO C SUB,1-12}; R SUP,4} ES HIDROGENO, HIDROXI, ALQUILO C SUB,1-6}, ALQUILOXI C SUB,1-6}, AMINO, MONO 1-6})AMINO O UN ANILLO HETEROCICLICO OPCIONALMENTE SUSTITUIDO; R SUP,5} Y R SUP,7} SON CADA UNO INDEPENDIENTEMENTE HIDROGENO, ALQUILO C SUB,1-6}, ALQUILOXI C SUB,1-6}, AMINO, MONO LQUIL C SUB,1-6})AMINO O UN ANILLO HETEROCICLICO OPCIONALMENTE SUSTITUIDO; R SUP,6} ES HIDROGENO O ALQUILO C SUB,1-6}; Y ARILO ES FENILO O FENILO SUSTITUIDO CON 1, 2 O 3 SUSTITUYENTES SELECCIONADOS ENTRE HALO, ALQUILO C SUB,1-6} O ALQUILOXI C SUB,1-6}. ADEMAS TRATA DE COMPOSICIONES FARMACEUTICAS QUE LOSCONTIENEN, DE PROCEDIMIENTOS PARA PREPARAR DICHOS COMPUESTOS Y COMPOSICIONES, Y EL USO DE LOS MISMOS COMO MEDICINA, EN PARTICULAR EN TRASTORNOS QUE IMPLICAN UN VACIADO GASTRICO DISMINUIDO.
ES96916121T 1995-05-23 1996-05-15 Derivados de (2-morfolinilmetil)benzamida. Expired - Lifetime ES2167563T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95201350 1995-05-23

Publications (1)

Publication Number Publication Date
ES2167563T3 true ES2167563T3 (es) 2002-05-16

Family

ID=8220318

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96916121T Expired - Lifetime ES2167563T3 (es) 1995-05-23 1996-05-15 Derivados de (2-morfolinilmetil)benzamida.

Country Status (18)

Country Link
US (1) US6100262A (es)
EP (1) EP0827500B1 (es)
JP (1) JPH11505815A (es)
KR (1) KR100446099B1 (es)
AT (1) ATE208766T1 (es)
AU (1) AU710037B2 (es)
CA (1) CA2220140C (es)
DE (1) DE69617001T2 (es)
DK (1) DK0827500T3 (es)
ES (1) ES2167563T3 (es)
IL (1) IL118379A (es)
MY (1) MY117938A (es)
NO (1) NO309900B1 (es)
NZ (1) NZ309065A (es)
PT (1) PT827500E (es)
TW (1) TW505639B (es)
WO (1) WO1996037486A1 (es)
ZA (1) ZA964100B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2423251A1 (en) 2000-09-29 2002-04-04 Glaxo Group Limited Morpholin-acetamide derivatives for the treatment of inflammatory diseases
UA77515C2 (en) * 2002-04-04 2006-12-15 Diazabicyclo alkane derivatives possessing neuroldnin-nk1 receptor antagonistic activity
TWI423967B (zh) * 2008-02-21 2014-01-21 Dainippon Sumitomo Pharma Co 醯胺衍生物及含有其之醫藥組合物
TWI903299B (zh) 2018-03-08 2025-11-01 美商英塞特公司 作為PI3K-γ抑制劑之胺基吡嗪二醇化合物
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
CN110938068B (zh) * 2019-11-06 2022-12-23 广东东阳光药业有限公司 N-(吗啉-2-基甲基)酰胺衍生物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870074A (en) * 1986-04-30 1989-09-26 Dainippon Pharmaceutical Co., Ltd. Substituted benzamide derivatives, for enhancing gastrointestinal motility
EP0774460A1 (en) * 1994-03-30 1997-05-21 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compound and use thereof as medicine

Also Published As

Publication number Publication date
JPH11505815A (ja) 1999-05-25
ATE208766T1 (de) 2001-11-15
KR100446099B1 (ko) 2004-11-10
EP0827500A1 (en) 1998-03-11
EP0827500B1 (en) 2001-11-14
NO975342D0 (no) 1997-11-21
KR19990008144A (ko) 1999-01-25
NZ309065A (en) 1999-06-29
IL118379A0 (en) 1996-09-12
PT827500E (pt) 2002-04-29
MY117938A (en) 2004-08-30
ZA964100B (en) 1997-11-24
US6100262A (en) 2000-08-08
TW505639B (en) 2002-10-11
IL118379A (en) 1999-12-31
AU5899296A (en) 1996-12-11
NO309900B1 (no) 2001-04-17
WO1996037486A1 (en) 1996-11-28
CA2220140C (en) 2008-02-12
CA2220140A1 (en) 1996-11-28
DE69617001T2 (de) 2002-07-11
DK0827500T3 (da) 2002-02-25
AU710037B2 (en) 1999-09-09
NO975342L (no) 1997-11-21
DE69617001D1 (de) 2001-12-20

Similar Documents

Publication Publication Date Title
SV1998000029A (es) Compuestos de pirazina ref. pg3186
ES2188957T3 (es) N-(4-(heteroarilmetil)fenil)-heteroarilaminas.
ECSP941122A (es) Derivados de 5-arilindoles
DE59309786D1 (de) Enniatine und enniatinderivate zur bekämpfung von endoparasiten
ES2193660T3 (es) Derivados de pirimidina inhibidores de vih.
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
ES2084944T3 (es) Amidas terapeuticas.
ES2121896T3 (es) Derivados de acido hidroxamico como inhibidores de colagenasa.
UY28026A1 (es) 4-piperazinilbencenosulfonilindoles y usos de los mismos.
PT758248E (pt) Formulacoes para o factor ix
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
ATE216590T1 (de) Arzneimittelformulierungen für il-12
ES2175350T3 (es) Compuestos triciclicos que tienen afinidad de union a receptores de melatonina, su produccion y uso.
ES2128092T3 (es) Derivados de anilina.
ECSP034428A (es) Ciclopentanoindoles, composiciones conteniendo tales compuestos y su uso
ES2096560T3 (es) Compuestos de benzocicloheptapiridina sustituida con fluor, composiciones y metodos para uso como compuestos antihistaminicos.
MX9300407A (es) Derivados azabiciclicos usados en la fabricacion de medicamentos, composiciones que los contienen y procedimiento para su preparacion.
SE9702564D0 (sv) New compounds
MX9301197A (es) Derivados de indol.
AR015448A1 (es) COMBINACIoN DE UN INHIBIDOR DE REABSORCIoN DE 5-HT CON UN ANTAGONISTA O AGONISTA PARCIAL DE H5-HT1B, PROCESO PARA SU PREPARACIoN, FORMULACIoN FARMACÉUTICA QUE LA CONTIENE, SU USO PARA PREPARAR MEDICAMENTOS PARA TRATAR TRASTORNOS AFECTIVOS Y KIT QUE CONTIENE DICHA COMBINACIoN
ES2046671T3 (es) Un procedimiento para la preparacion de tetrahidroimidazo(1,4)benzodiazepin-2-tionas.
NO20000737D0 (no) Tetrahydro <gamma>-karboliner
ES2167563T3 (es) Derivados de (2-morfolinilmetil)benzamida.
ES2149193T3 (es) Compuestos heterociclicos sustituidos con alquilo.
ATE227122T1 (de) Stabilisierte tablettenformulierung